Effect of 48 Hours of Treatment With the Natural Peptide-Hormone GLP-1 in Patients With Chronic Heart Failure
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether 48 hours of glucagon-like-peptide-1 (GLP-1)
infusion can improve heart function and alter substrate metabolism in non-diabetic patients
with heart failure.